Ciprofloxacin eye drops: a new funded brand
Ciprofloxacin eye drops are an antibiotic used to treat certain types of eye infections caused by bacteria.
These bacterial infections are called bacterial keratitis or severe bacterial conjunctivitis. To understand more about these infections and if this medicine is right for you talk to your doctor, nurse or pharmacist.
The funded brand of ciprofloxacin eye drops is changing from Ciloxan to Ciprofloxacin Teva. This means Ciloxan will no longer be funded.
Your new brand is available from 1 April 2018
Ciprofloxacin Teva will be available from 1 April 2018. The timing may vary, so check with your pharmacist when you can expect the new brand.
We expect the dates of the change to be:
- From 1 April 2018 Ciprofloxacin Teva will be fully funded.
- From 1 June 2018 a part payment may be required for Ciloxan.
- From 1 September 2018 Ciprofloxacin Teva will be fully funded. Ciloxan will no longer be funded.
If you want to keep using your current brand of ciprofloxacin eye drops 0.3%, you can ask your pharmacist to check the price and availability.
The way you first open the Ciprofloxacin Teva eye drops is different.
The tip of the bottle is sealed. There’s a spike inside the lid that can break the seal.
Before you use the eye drops for the first time, screw the lid down tightly to twist the spike through the seal on the bottle.
It’s understandable you might have questions about medicine brand changes, but you shouldn’t notice any difference when you change to Ciprofloxacin Teva. If you have any questions or concerns about changes to medicines, you should talk with your doctor, nurse or pharmacist.
There’s more information about medicines and changes to medicines on PHARMAC’s website: The facts about generic and biosimilar medicines.
Last updated: 15 March 2018